Role of Early Versus Late Switch to Lapatinib-Capecitabine

TerminatedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

July 15, 2010

Primary Completion Date

December 13, 2010

Study Completion Date

December 13, 2010

Conditions
Cancer
Interventions
DRUG

Treatment

Patients treated with Lapatinib-capecitabine after Trastuzumab progression

Trial Locations (13)

40110150

GSK Investigational Site, Salvador

29055-270

GSK Investigational Site, Vitória

41810-570

GSK Investigational Site, Salvador

41825-010

GSK Investigational Site, Salvador

74140-050

GSK Investigational Site, Goiânia

74605-070

GSK Investigational Site, Goiânia

59075-740

GSK Investigational Site, Natal

90430-090

GSK Investigational Site, Porto Alegre

88034-000

GSK Investigational Site, Florianópolis

Unknown

GSK Investigational Site, São José dos Campos

GSK Investigational Site, Belo Horizonte

22793-080

GSK Investigational Site, Rio de Janeiro

01239-040

GSK Investigational Site, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY